Ranibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 Study

NCT02511067 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding lost and study never started

Conditions

Diabetic Macular Edema

Interventions

DRUG: Tocilizumab
DRUG: Ranibizumab

Sponsor

University of Nebraska

Collaborators

[object Object]